FDA Approves Combo Treatment for Stomach, GE Junction Adenocarcinoma
The US Food and Drug Administration (FDA) today approved a new combination treatment for patients with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma.